The Indian Institute of Management Nagpur (IIM Nagpur), one of the fastest growing IIMs renowned for contemporary business ...

The general view being put forward in the purpose arena is that having a societally lofty corporate purpose is the most ...

AI payoff is a maturity problem: tangible returns happen when you rewire how work gets done and how you plan to win.

Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

In today’s cosmetic industry, scientific validation has become the foundation of product credibility. Consumers no longer ...

The collaboration unites complementary scientific and technical expertise to provide seamless solutions across the biopharmaceutical value chain ...

The Trump administration released its much-anticipated National Security Strategy this week. CFR convened six of its experts ...

APONVIE, an aprepitant product, highlighted as the only FDA-approved IV formulation Neurokinin-1 ('NK-1”) antagonist ...

The SCS Microinjector is a proven in-office, repeatable, non-surgical procedure for the targeted delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and ...

Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human ...

A live webcast of the conference call will be available on the Company's website at https://ir.nrxpharma.com/events. Participants that are unable to join the webcast can access the conference call via ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company developing novel therapies in oncology, including (Z)-endoxifen, to improve outcomes for patients across the ...